Cerecor, Inc. Regains Compliance with NASDAQ Minimum Bid Price Requirement
BALTIMORE, MD--(Marketwired - October 18, 2017) - Cerecor, Inc. (NASDAQ: CERC), a biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that it received a letter from …